Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Can aggressive Forms of Ductal Carcinoma In Situ Be Identified with Molecular Markers?
FY 2018-19
Summary
Breast cancer is the most common type of cancer in women. 1 in 5 women diagnosed with breast cancer will have a preinvasive type of cancer called ductal carcinoma in situ (DCIS). We know that roughly 20-30% of DCIS will progress to become invasive cancers. They do this by crossing what is known as the basement membrane, a layer forming a protective barrier preventing cancers from spreading in the body. However, it is not currently known which DCIS will become invasive or why. We therefore treat all DCIS the same way, with surgery followed by radiation therapy to the chest to prevent recurrence and transformation into invasive cancer. Our hypothesis is that, by determining what causes DCIS to cross the basement membrane, we could determine which DCIS are more likely to become invasive cancers. Our objective is therefore to study DCIS samples from real patients in animal models and to examine what characterizes a DCIS with invasive potential, and how they differ from more indolent DCIS. Eventually, it is our hope that this would allow us to predict, from a patient’s biopsy, whether the patient’s DCIS requires aggressive treatment, or if it can rather be observed, thus preventing the patient from needing surgery and radiation therapy.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
415329
Name
Di Lena Elise
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Can aggressive Forms of Ductal Carcinoma In Situ Be Identified with Molecular Markers?
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Basement Membrane; Breast Cancer; Ductal Carcinoma In Situ; Invasive Ductal Carcinoma; Patient Derived Xenografts
Abstract
Breast cancer is the most common type of cancer in women. 1 in 5 women diagnosed with breast cancer will have a preinvasive type of cancer called ductal carcinoma in situ (DCIS). We know that roughly 20-30% of DCIS will progress to become invasive cancers. They do this by crossing what is known as the basement membrane, a layer forming a protective barrier preventing cancers from spreading in the body. However, it is not currently known which DCIS will become invasive or why. We therefore treat all DCIS the same way, with surgery followed by radiation therapy to the chest to prevent recurrence and transformation into invasive cancer. Our hypothesis is that, by determining what causes DCIS to cross the basement membrane, we could determine which DCIS are more likely to become invasive cancers. Our objective is therefore to study DCIS samples from real patients in animal models and to examine what characterizes a DCIS with invasive potential, and how they differ from more indolent DCIS. Eventually, it is our hope that this would allow us to predict, from a patient’s biopsy, whether the patient’s DCIS requires aggressive treatment, or if it can rather be observed, thus preventing the patient from needing surgery and radiation therapy.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Di Lena, Elise
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~